(IN BRIEF) Researchers from UCSF and the Technical University of Munich (TUM) have developed engineered regulatory immune cells to precisely modulate the immune system, addressing conditions like type 1 diabetes, autoimmune diseases, and organ transplant rejection. Unlike traditional immunosuppressants, this … Read the full press release →
Posted in Business, Education, Financial, Germany, Healthcare, Industrial, Investment, Management, News, Science, Technology
Tagged Dr. Hasna Maachi, Engineered Immune Cells, inflammatory disorders, partnership, Professor Matthias Hebrok, sustainability, TUM, type 1 diabetes, UCSF, Wendell Lim